Pricing pressure and regulatory restrictions across various healthcare industries have called for more detailed evidence of outcomes
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

